20-Year study to track rare bone marrow diseases
NCT ID NCT05012111
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 10 times
Summary
This study follows people with acquired or inherited bone marrow failure for up to 20 years to learn how the diseases and treatments affect the body over time. Participants, aged 2 and older, will have regular check-ups and tests every 1 to 3 years. The goal is to better understand long-term outcomes, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide crucial insights into how bone marrow failure diseases progress and affect organs over time, guiding future treatments.
- What could go wrong
- This is an observational study, not testing a new treatment, so it won't directly improve health. It may take many years to yield useful results, and some participants may find the frequent tests burdensome.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHERITED BONE MARROW FAILURE SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Half-Matched stem cell transplant offers hope for children with blood disorders
- New transplant method aims to reduce complications in bone marrow failure patients
- New transplant approach aims to tame bone marrow failure
- New drug combo aims to make bone marrow transplants safer for kids
- New hope for older adults with rare blood disorder: safer transplant regimen under study